Filed Pursuant to Rule 424(b)(5)
Registration No. 333-270763
PROSPECTUS SUPPLEMENT
(To Prospectus Dated March 23, 2023)

$500,000,000
Regency Centers Corporation
Common Stock
We have entered into separate equity distribution agreements with each of Wells Fargo Securities, LLC, J.P. Morgan Securities LLC, Jefferies LLC, Truist Securities, Inc., BTIG, LLC, BofA Securities, Inc., Mizuho Securities USA LLC, TD Securities (USA) LLC, BMO Capital Markets Corp., Regions Securities LLC, Scotia Capital (USA) Inc., and BNY Mellon Capital Markets, LLC, each a sales agent and collectively, the sales agents, relating to our shares of common stock, par value $0.01 per share, offered by this prospectus supplement and the accompanying prospectus pursuant to a continuous offering program. In accordance with the terms of the equity distribution agreements, we may from time to time offer and sell shares of common stock having an aggregate offering price of up to $500,000,000 through the sales agents (acting in their capacity as sales agents or as forward sellers, as described below). The offer and sale of our common stock as described in this prospectus supplement replaces the prior continuous offering program previously established by us in May 2020.
The equity distribution agreements provide that, in addition to the issuance and sale of shares of our common stock by us through the sales agents, we also may enter into forward sale agreements under separate master forward confirmations and one or more related supplemental confirmations between us and each of Wells Fargo Bank, National Association, JPMorgan Chase Bank, National Association, Bank of America, N.A., Mizuho Markets Americas LLC, The Toronto-Dominion Bank, Bank of Montreal, Jefferies LLC, The Bank of Nova Scotia, Truist Bank, BNY Mellon Capital Markets, LLC, Nomura Global Financial Products, Inc. and Regions Securities LLC. We refer to each of these entities as a forward purchaser and collectively as forward purchasers. In connection with each particular forward sale agreement, the relevant forward purchaser or its affiliate will, at our request, borrow from third parties and, through its related sales agent, sell a number of shares of our common stock equal to the number of shares of our common stock underlying the particular forward sale agreement. We refer to the sales agents, when selling such shares of our common stock, as forward sellers, except in the case of BTIG, LLC, for which references to forward sellers refer instead to Nomura Securities International, Inc. (acting through BTIG, LLC as agent). In no event will the aggregate number of shares of our common stock sold through the forward sellers and sales agents, whether as an agent for us or as a forward seller, under the equity distribution agreements and under any forward sale agreements, have an aggregate sales price in excess of $500,000,000.
We also may sell some or all of the shares of common stock to a sales agent as principal for its own account at a price agreed upon at the time of sale.
Sales of our common stock, if any, under this prospectus supplement and the accompanying prospectus may be made in negotiated transactions or transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act, including sales made by means of ordinary brokers’ transactions, including directly on The Nasdaq Stock Market LLC, or NASDAQ, or sales made to or through a market maker other than on an exchange. The sales agents are not required to sell any specific number or dollar amount of common stock, but as instructed by us will make all sales using commercially reasonable efforts, consistent with their normal trading and sales practices, as our sales agents and subject to the terms of the equity distribution agreements.
We will not initially receive any proceeds from the sale of borrowed shares of our common stock by a forward seller. We expect to fully physically settle each particular forward sale agreement with the relevant forward purchaser on one or more dates specified by us on or prior to the maturity date of that particular forward sale agreement, in which case we will expect to receive aggregate net cash proceeds at settlement equal to the number of shares underlying the particular forward sale agreement multiplied by the relevant forward sale price. However, we may also elect to cash settle or net share settle a particular forward sale agreement, in which case we may not receive any proceeds (in the case of cash settlement) or will not receive any proceeds (in the case of net share settlement), and we may owe cash (in the case of cash settlement) or shares of common stock (in the case of net share settlement) to the relevant forward purchaser.
The common stock to which this prospectus supplement relates will be offered and sold through the sales agents over a period of time and from time to time in transactions at then-current prices. Each sales agent will be entitled to compensation that will not exceed 2.0% of the gross sales price per share for any common stock sold through it. In connection with the sale of common stock on our behalf, the sales agents may be deemed to be “underwriters” within the meaning of the Securities Act, and the compensation of the sales agents may be deemed to be underwriting discounts or commissions. In connection with each forward sale agreement, we will pay the relevant forward seller, in the form of a reduced initial forward sale price under the related forward sale agreement with the related forward purchaser, commissions at a mutually agreed rate that will not exceed 2.0% of the gross sales prices of all borrowed shares of common stock sold during the applicable forward hedge selling period by it as a forward seller. If any sales agent and/or forward seller, as applicable, engages in special selling efforts, as that term is used in Regulation M under the Securities Exchange Act of 1934, as amended, such sales agent and/or forward seller, as applicable, will receive from us a commission to be agreed upon at the time of sale.
Our common stock is listed on NASDAQ under the symbol “REG”. On August 7, 2023, the last reported sale price of our common stock on NASDAQ was $66.64 per share.
To preserve our status as a real estate investment trust, or REIT, for federal income tax purposes, among other purposes, our charter imposes certain restrictions on the ownership of our common stock. See “Description of the Securities That May Be Offered by Regency Centers Corporation — Restrictions on Ownership of Capital Stock” in the accompanying prospectus.
Investing in our common stock involves risks. See “Risk Factors” beginning on page S-7 of this prospectus supplement and in our Annual Report on Form 10-K for the year ended December 31, 2022 and our other periodic reports filed with the Securities and Exchange Commission, or the SEC, and incorporated by reference herein.
Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | |
Wells Fargo Securities | | J.P. Morgan | | Jefferies |
Truist Securities | | BTIG | | BofA Securities |
Mizuho | | TD Securities | | BMO Capital Markets |
Regions Securities LLC | | Scotiabank | | BNY Mellon Capital Markets, LLC |
The date of this Prospectus Supplement is August 8, 2023.